Mechanisms of altered redox regulation in neurodegenerative diseases-focus on S-glutathionylation

Antioxidants and Redox Signaling

Volumn 16, Issue 6, 2012, Pages 543-566

  Sabens Liedhegner, Elizabeth A ^a   Gao, Xing Huang ^b   Mieyal, John J ^b,c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; APOPTOSIS SIGNAL REGULATING KINASE 1; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOCHROME C OXIDASE; DJ 1 PROTEIN; GLUTAREDOXIN; GLUTATHIONE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEAT SHOCK PROTEIN 72; HEAT SHOCK PROTEIN 90; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; ISOCITRATE DEHYDROGENASE (NADP); LEVODOPA; NITRIC OXIDE SYNTHASE; OXOGLUTARATE DEHYDROGENASE; PROTEIN P53; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); TAU PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TYROSINE 3 MONOOXYGENASE; UBIQUINOL CYTOCHROME C REDUCTASE; UNINDEXED DRUG; VOLTAGE DEPENDENT ANION CHANNEL;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; AUTOPHAGY; BIOTRANSFORMATION; BLOOD BRAIN BARRIER; BRAIN CORTEX; CALCIUM TRANSPORT; CATECHOLAMINE NERVE CELL; CELL DEATH; CELL DIFFERENTIATION; CELL SURVIVAL; CHEMICAL REACTION; CORPUS STRIATUM; CYTOSOL; DEGENERATIVE DISEASE; DISEASE COURSE; FRIEDREICH ATAXIA; GENE MUTATION; GENE SILENCING; HUNTINGTON CHOREA; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; MITOCHONDRIAL RESPIRATION; NITROSATIVE STRESS; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN HOMEOSTASIS; PROTEIN MODIFICATION; REGULATORY MECHANISM; REVIEW; S GLUTATHIONYLATION; SIGNAL TRANSDUCTION; STEADY STATE; SUBSTANTIA NIGRA;

ANIMALS; GLUTATHIONE; HUMANS; NEURODEGENERATIVE DISEASES; OXIDATION-REDUCTION;

EID: 84856745322     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.4119     Document Type: Review

References (203)

1. Adachi T, Pimentel DR, Heibeck T, Hou X, Lee YJ, Jiang B, Ido Y, and Cohen RA. S-glutathiolation of Ras mediates redox-sensitive signaling by angiotensin II in vascular smooth muscle cells. J Biol Chem 279: 29857-29862, 2004. (Pubitemid 38915870)
2. Adachi T, Weisbrod RM, Pimentel DR, Ying J, Sharov VS, Schoneich C, and Cohen RA. S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat Med 10: 1200-1207, 2004. (Pubitemid 39540436)
3. Adam-Vizi V. Production of reactive oxygen species in brain mitochondria: Contribution by electron transport chain and non-electron transport chain sources. Antioxid Redox Signal 7: 1140-1149, 2005. (Pubitemid 41232509)
4. Aksenov MY, Aksenova MV, Butterfield DA, Geddes JW, and Markesbery WR. Protein oxidation in the brain in Alzheimer's disease. Neuroscience 103: 373-383, 2001. (Pubitemid 32201924)
5. Akterin S, Cowburn RF, Miranda-Vizuete A, Jimenez A, Bogdanovic N, Winblad B, and Cedazo-Minguez A. Involvement of glutaredoxin-1 and thioredoxin-1 in betaamyloid toxicity and Alzheimer's disease. Cell Death Differ 13: 1454-1465, 2006. (Pubitemid 44210349)
6. Ansari MA and Scheff SW. Oxidative stress in the progression of Alzheimer disease in the frontal cortex. J Neuropathol Exp Neurol 69: 155-167, 2010.
7. Ara J, Przedborski S, Naini AB, Jackson-Lewis V, Trifiletti RR, Horwitz J, and Ischiropoulos H. Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP). Proc Natl Acad Sci USA 95: 7659-7663, 1998. (Pubitemid 28293309)
8. Aracena-Parks P, Goonasekera SA, Gilman CP, Dirksen RT, Hidalgo C, and Hamilton SL. Identification of cysteines involved in S-nitrosylation, S-glutathionylation, and oxidation to disulfides in ryanodine receptor type 1. J Biol Chem 281: 40354-40368, 2006. (Pubitemid 46043301)
9. Aram L, Geula S, Arbel N, and Shoshan-Barmatz V. VDAC1 cysteine residues: Topology and function in channel activity and apoptosis. Biochem J 427: 445-454, 2010.
10. Aran M, Ferrero DS, Pagano E, and Wolosiuk RA. Typical 2-Cys peroxiredoxins-Modulation by covalent transformations and noncovalent interactions. FEBS J 276: 2478-2493, 2009.
11. Armentero MT, Pinna A, Ferre S, Lanciego JL, Muller CE, and Franco R. Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease. Pharmacol Ther 132: 280-299, 2011.
12. Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA, Brunskill EW, Sayen MR, Gottlieb RA, Dorn GW, Robbins J, and Molkentin JD. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434: 658-662, 2005. (Pubitemid 40488559)
13. Baines CP, Kaiser RA, Sheiko T, Craigen WJ, and Molkentin JD. Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat Cell Biol 9: 550-555, 2007. (Pubitemid 46696536)
14. Bandyopadhyay S, Starke DW, Mieyal JJ, and Gronostajski RM. Thioltransferase (glutaredoxin) reactivates the DNAbinding activity of oxidation-inactivated nuclear factor I. J Biol Chem 273: 392-397, 1998. (Pubitemid 28042223)
15. Barrett WC, DeGnore JP, Keng YF, Zhang ZY, Yim MB, and Chock PB. Roles of superoxide radical anion in signal transduction mediated by reversible regulation of proteintyrosine phosphatase 1B. J Biol Chem 274: 34543-34546, 1999. (Pubitemid 129509489)
16. Barrett WC, DeGnore JP, Konig S, Fales HM, Keng YF, Zhang ZY, Yim MB, and Chock PB. Regulation of PTP1B via glutathionylation of the active site cysteine 215. Biochemistry 38: 6699-6705, 1999.
17. Bedard K and Krause KH. The NOX family of ROSgenerating NADPH oxidases: Physiology and pathophysiology. Physiol Rev 87: 245-313, 2007. (Pubitemid 46209993)
18. Beer SM, Taylor ER, Brown SE, Dahm CC, Costa NJ, Runswick MJ, and Murphy MP. Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins: Implications for mitochondrial redox regulation and antioxidant DEFENSE. J Biol Chem 279: 47939-47951, 2004. (Pubitemid 39540945)
19. Belzacq AS, Vieira HL, Verrier F, Vandecasteele G, Cohen I, Prevost MC, Larquet E, Pariselli F, Petit PX, Kahn A, Rizzuto R, Brenner C, and Kroemer G. Bcl-2 and Bax modulate adenine nucleotide translocase activity. Cancer Res 63: 541-546, 2003. (Pubitemid 36152519)
20. Benhar M, Forrester MT, and Stamler JS. Protein denitrosylation: Enzymatic mechanisms and cellular functions. Nat Rev Mol Cell Biol 10: 721-732, 2009.
21. Borges CR, Geddes T, Watson JT, and Kuhn DM. Dopamine biosynthesis is regulated by S-glutathionylation. Potential mechanism of tyrosine hydroxylase inhibition during oxidative stress. J Biol Chem 277: 48295-48302, 2002. (Pubitemid 35470783)
22. Bossy B, Petrilli A, Klinglmayr E, Chen J, Lutz-Meindl U, Knott AB, Masliah E, Schwarzenbacher R, and Bossy- Wetzel E. S-Nitrosylation of DRP1 does not affect enzymatic activity and is not specific to Alzheimer's disease. J Alzheimers Dis 20 Suppl 2: S513-S526, 2010.
23. Bredesen DE, Rao RV, and Mehlen P. Cell death in the nervous system. Nature 443: 796-802, 2006. (Pubitemid 44622684)
24. Brochard V, Combadiere B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V, Bonduelle O, Varez-Fischer D, Callebert J, Launay JM, Duyckaerts C, Flavell RA, Hirsch EC, and Hunot S. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest 119: 182-192, 2009.
25. Bull R, Finkelstein JP, Galvez J, Sanchez G, Donoso P, BehrensMI, and Hidalgo C. Ischemia enhances activation by Ca2 + and redox modification of ryanodine receptor channels from rat brain cortex. J Neurosci 28: 9463-9472, 2008.
26. Calabrese V, Cornelius C, Rizzarelli E, Owen JB, Dinkova- Kostova AT, and Butterfield DA. Nitric oxide in cell survival: A janus molecule. Antioxid Redox Signal 11: 2717-2739, 2009.
27. Candore G, Bulati M, Caruso C, Castiglia L, Colonna- Romano G, Di BD, Duro G, Lio D, Matranga D, Pellicano M, Rizzo C, Scapagnini G, and Vasto S. Inflammation, cytokines, immune response, apolipoprotein E, cholesterol, and oxidative stress in Alzheimer disease: Therapeutic implications. Rejuvenation Res 13: 301-313, 2010.
28. Carbone DL, Doorn JA, Kiebler Z, Ickes BR, and Petersen DR. Modification of heat shock protein 90 by 4- hydroxynonenal in a rat model of chronic alcoholic liver disease. J Pharmacol Exp Ther 315: 8-15, 2005. (Pubitemid 41380492)
29. Carbone DL, Doorn JA, Kiebler Z, Sampey BP, and Petersen DR. Inhibition of Hsp72-mediated protein refolding by 4-hydroxy-2-nonenal. Chem Res Toxicol 17: 1459-1467, 2004. (Pubitemid 39532315)
30. Casagrande S, Bonetto V, Fratelli M, Gianazza E, Eberini I, Massignan T, Salmona M, Chang G, Holmgren A, and Ghezzi P. Glutathionylation of human thioredoxin: A possible crosstalk between the glutathione and thioredoxin systems. Proc Natl Acad Sci USA 99: 9745-9749, 2002. (Pubitemid 34831118)
31. Cenini G, Sultana R, Memo M, and Butterfield DA. Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease. Free Radic Biol Med 45: 81-85, 2008.
32. Chen CA, Wang TY, Varadharaj S, Reyes LA, Hemann C, Talukder MA, Chen YR, Druhan LJ, and Zweier JL. Sglutathionylation uncouples eNOS and regulates its cellular and vascular function. Nature 468: 1115-1118, 2010.
33. Chen CL, Chen J, Rawale S, Varadharaj S, Kaumaya PP, Zweier JL, and Chen YR. Protein tyrosine nitration of the flavin subunit is associated with oxidative modification of mitochondrial complex II in the post-ischemic myocardium. J Biol Chem 283: 27991-28003, 2008.
34. Chen VT, Huang CL, Lee YC, Liao WC, and Huang NK. The roles of the thioredoxin system and peroxiredoxins in 1-methyl-4-phenyl-pyridinium ion-induced cytotoxicity in rat pheochromocytoma cells. Toxicol In Vitro 1577-1583, 2010.
35. Chen YR, Chen CL, Pfeiffer DR, and Zweier JL. Mitochondrial complex II in the post-ischemic heart: oxidative injury and the role of protein S-glutathionylation. J Biol Chem 282: 32640-32654, 2007. (Pubitemid 350159288)
36. Choubey V, Safiulina D, Vaarmann A, Cagalinec M, Wareski P, Kuum M, Zharkovsky A, and Kaasik A. Mutant A53T alpha-synuclein induces neuronal death by increasing mitochondrial autophagy. J Biol Chem 286: 10814-10824, 2011.
37. Chung KK, Thomas B, Li X, Pletnikova O, Troncoso JC, Marsh L, Dawson VL, and Dawson TM. S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science 304: 1328-1331, 2004. (Pubitemid 38697430)
38. Chung S, Sundar IK, Yao H, Ho YS, and Rahman I. Glutaredoxin 1 regulates cigarette smoke-mediated lung inflammation through differential modulation of I{kappa}B kinases in mice: Impact on histone acetylation. Am J Physiol Lung Cell Mol Physiol 299: L192-L203, 2010.
39. Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, Sakaguchi H, Kamei M, Hasan A, Yan L, Rayborn ME, Salomon RG, and Hollyfield JG. Drusen proteome analysis: An approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA 99: 14682-14687, 2002. (Pubitemid 35334544)
40. Dagda RK and Chu CT. Mitochondrial quality control: Insights on how Parkinson's disease related genes PINK1, parkin, and Omi/HtrA2 interact to maintain mitochondrial homeostasis. J Bioenerg Biomembr 41: 473-479, 2009.
41. Daily D, Vlamis-Gardikas A, Offen D, Mittelman L, Melamed E, Holmgren A, and Barzilai A. Glutaredoxin protects cerebellar granule neurons from dopamineinduced apoptosis by activating NF-kappa B via Ref-1. J Biol Chem 276: 1335-1344, 2001. (Pubitemid 32096564)
42. Daily D, Vlamis-Gardikas A, Offen D, Mittelman L, Melamed E, Holmgren A, and Barzilai A. Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by dual activation of the ras-phosphoinositide 3-kinase and jun n-terminal kinase pathways. J Biol Chem 276: 21618-21626, 2001.
43. Davis DA, Newcomb FM, Starke DW, Ott DE, Mieyal JJ, and Yarchoan R. Thioltransferase (glutaredoxin) is detected within HIV-1 and can regulate the activity of glutathionylated HIV-1 protease in vitro. J Biol Chem 272: 25935-25940, 1997. (Pubitemid 27438920)
44. Demasi M, Silva GM, and Netto LE. 20 S proteasome from Saccharomyces cerevisiae is responsive to redox modifications and is S-glutathionylated. J Biol Chem 278: 679-685, 2003. (Pubitemid 36043622)
45. Di Noto L. Biochemical Investigation of Tau and MAP2: Polymerization implications for neuropathic filament assembly in Alzheimer's disease (Dissertation). University of Florida, Gainsville, FL, 2002.
46. Di Noto L, Deture MA, and Purich DL. Structural insights into Alzheimer filament assembly pathways based on sitedirected mutagenesis and S-glutathionylation of threerepeat neuronal Tau protein. Microsc Res Tech 67: 156-163, 2005. (Pubitemid 41243633)
47. Di DF, Cenini G, Sultana R, Perluigi M, Uberti D, Memo M, and Butterfield DA. Glutathionylation of the pro-apoptotic protein p53 in Alzheimer's disease brain: Implications for AD pathogenesis. Neurochem Res 34: 727-733, 2009.
48. Dickinson BC, Peltier J, Stone D, Schaffer DV, and Chang CJ. Nox2 redox signaling maintains essential cell populations in the brain. Nat Chem Biol 7: 106-112, 2011.
49. Double KL, Todd G, and Duma SR. Pathophysiology of transcranial sonography signal changes in the human substantia nigra. Int Rev Neurobiol 90: 107-120, 2010.
50. Du ZX, Yan Y, Zhang HY, Liu BQ, Gao YY, Niu XF, Guan Y, Meng X, and Wang HQ. Suppression of MG132- mediated cell death by peroxiredoxin 1 through influence on ASK1 activation in human thyroid cancer cells. Endocr Relat Cancer 17: 553-560, 2010.
51. Ehrhart J, Gluck M, Mieyal J, and Zeevalk GD. Functional glutaredoxin (thioltransferase) activity in rat brain and liver mitochondria. Parkinsonism Relat Disord 8: 395-400, 2002. (Pubitemid 36157326)
52. Farina C, Aloisi F, and Meinl E. Astrocytes are active players in cerebral innate immunity. Trends Immunol 28: 138-145, 2007. (Pubitemid 46283692)
53. Fatania HR, al-Nassar KE, and Thomas N. Chemical modification of rat liver cytosolic NADP( + )-linked isocitrate dehydrogenase by N-ethylmaleimide. Evidence for essential sulphydryl groups. FEBS Lett 322: 245-248, 1993. (Pubitemid 23144697)
54. Ferri A, Fiorenzo P, Nencini M, Cozzolino M, Pesaresi MG, Valle C, Sepe S, Moreno S, and Carri MT. Glutaredoxin 2 prevents aggregation of mutant SOD1 in mitochondria and abolishes its toxicity. Hum Mol Genet 19: 4529-4542, 2010.
55. Ferrington DA and Kapphahn RJ. Catalytic site-specific inhibition of the 20S proteasome by 4-hydroxynonenal. FEBS Lett 578: 217-223, 2004. (Pubitemid 39601784)
56. Findlay VJ, Townsend DM, Morris TE, Fraser JP, He L, and Tew KD. A novel role for human sulfiredoxin in the reversal of glutathionylation. Cancer Res 66: 6800-6806, 2006. (Pubitemid 44085640)
57. Floyd RA. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 222: 236-245, 1999. (Pubitemid 129708638)
58. Foster MW, Hess DT, and Stamler JS. Protein S-nitrosylation in health and disease: A current perspective. Trends Mol Med 15: 391-404, 2009.
59. Franco R and Cidlowski JA. Apoptosis and glutathione: Beyond an antioxidant. Cell Death Differ 16: 1303-1314, 2009.
60. Friguet B and Szweda LI. Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal crosslinked protein. FEBS Lett 405: 21-25, 1997 (Pubitemid 27130365)
61. Fujii H, Ichimori K, Hoshiai K, and Nakazawa H. Nitric oxide inactivates NADPH oxidase in pig neutrophils by inhibiting its assembling process. J Biol Chem 272: 32773-32778, 1997. (Pubitemid 28023609)
62. Fuxe KG, Tarakanov AO, Goncharova LB, and Agnati LF. A new road to neuroinflammation in Parkinson's disease? Brain Res Rev 58: 453-458, 2008.
63. Galganska H, Karachitos A, Wojtkowska M, Stobienia O, Budzinska M, and Kmita H. Communication between mitochondria and nucleus: Putative role for VDAC in reduction/oxidation mechanism. Biochim Biophys Acta 1797: 1276-1280, 2010.
64. Gallogly MM and Mieyal JJ. Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress. Curr Opin Pharmacol 7: 381-391, 2007. (Pubitemid 47304000)
65. Gallogly MM, Starke DW, and Mieyal JJ. Mechanistic and kinetic details of catalysis of thiol-disulfide exchange by glutaredoxins and potential mechanisms of regulation. Antioxid Redox Signal 11: 1059-1081, 2009.
66. Garcia J, Han D, Sancheti H, Yap LP, Kaplowitz N, and Cadenas E. Regulation of mitochondrial glutathione redox status and protein glutathionylation by respiratory substrates. J Biol Chem 285: 39646-39654, 2010.
67. Glass CK, Saijo K, Winner B, Marchetto MC, and Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell 140: 918-934, 2010.
68. Goos M, Zech WD, Jaiswal MK, Balakrishnan S, Ebert S, Mitchell T, Carri MT, Keller BU, and Nau R. Expression of a Cu,Zn superoxide dismutase typical for familial amyotrophic lateral sclerosis increases the vulnerability of neuroblastoma cells to infectious injury. BMC Infect Dis 7: 131, 2007.
69. 2-scavenging peroxidases. J Biol Chem 284: 31532-31540, 2009.
70. Haider L, Fischer MT, Frischer JM, Bauer J, Hoftberger R, Botond G, Esterbauer H, Binder CJ, Witztum JL, and Lassmann H. Oxidative damage in multiple sclerosis lesions. Brain 134: 1914-1924, 2011.
71. Halestrap AP, Clarke SJ, and Khaliulin I. The role of mitochondria in protection of the heart by preconditioning. Biochim Biophys Acta 1767: 1007-1031, 2007. (Pubitemid 47101788)
72. Hashemy SI, Johansson C, Berndt C, Lillig CH, and Holmgren A. Oxidation and S-nitrosylation of cysteines in human cytosolic and mitochondrial glutaredoxins: Effects on structure and activity. J Biol Chem 282: 14428-14436, 2007. (Pubitemid 47100442)
73. Heutink P. PINK-1 and DJ-1-new genes for autosomal recessive Parkinson's disease. J Neural Transm Suppl 215-219, 2006. (Pubitemid 44622202)
74. Hickey WF. Basic principles of immunological surveillance of the normal central nervous system. Glia 36: 118-124, 2001. (Pubitemid 33055900)
75. Hirsch EC and Hunot S. Neuroinflammation in Parkinson's disease: A target for neuroprotection? Lancet Neurol 8: 382-397, 2009.
76. Hu X, Weng Z, Chu CT, Zhang L, Cao G, Gao Y, Signore A, Zhu J, Hastings T, Greenamyre JT, and Chen J. Peroxiredoxin-2 protects against 6-hydroxydopamineinduced dopaminergic neurodegeneration via attenuation of the apoptosis signal-regulating kinase (ASK1) signaling cascade. J Neurosci 31: 247-261, 2011.
77. Hurd TR, Costa NJ, Dahm CC, Beer SM, Brown SE, Filipovska A, and Murphy MP. Glutathionylation of mitochondrial proteins. Antioxid Redox Signal 7: 999-1010, 2005. (Pubitemid 40967150)
78. Hurd TR, Requejo R, Filipovska A, Brown S, Prime TA, Robinson AJ, Fearnley IM, and Murphy MP. Complex I within oxidatively stressed bovine heart mitochondria is glutathionylated on Cys-531 and Cys-704 of the 75-kDa subunit: Potential role of CYS residues in decreasing oxidative damage. J Biol Chem 283: 24801-24815, 2008.
79. Imam SZ, Zhou Q, Yamamoto A, Valente AJ, Ali SF, Bains M, Roberts JL, Kahle PJ, Clark RA, and Li S. Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: Implications for Parkinson's disease. J Neurosci 31: 157-163, 2011.
80. Infanger DW, Sharma RV, and Davisson RL. NADPH oxidases of the brain: Distribution, regulation, and function. Antioxid Redox Signal 8: 1583-1596, 2006. (Pubitemid 44726333)
81. Iqbal K and Grundke-Iqbal I. Opportunities and challenges in developing Alzheimer disease therapeutics. Acta Neuropathol 122: 543-549, 2011.
82. Ischiropoulos H and Beckman JS. Oxidative stress and nitration in neurodegeneration: Cause, effect, or association? J Clin Invest 111: 163-169, 2003. (Pubitemid 36105911)
83. Jacob C, Knight I, and Winyard PG. Aspects of the biological redox chemistry of cysteine: From simple redox responses to sophisticated signalling pathways. Biol Chem 387: 1385-1397, 2006. (Pubitemid 44691419)
84. Jahngen-Hodge J, Obin MS, Gong X, Shang F, Nowell TR, Jr., Gong J, Abasi H, Blumberg J, and Taylor A. Regulation of ubiquitin-conjugating enzymes by glutathione following oxidative stress. J Biol Chem 272: 28218-28226, 1997. (Pubitemid 27517760)
85. Jenner P, Dexter DT, Sian J, Schapira AH, and Marsden CD. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group. Ann Neurol 32 Suppl: S82-S87, 1992.
86. Jha N, Kumar MJ, Boonplueang R, and Andersen JK. Glutathione decreases in dopaminergic PC12 cells interfere with the ubiquitin protein degradation pathway: Relevance for Parkinson's disease? J Neurochem 80: 555-561, 2002. (Pubitemid 34809963)
87. Junn E, Taniguchi H, Jeong BS, Zhao X, Ichijo H, and Mouradian MM. Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. Proc Natl Acad Sci USA 102: 9691-9696, 2005. (Pubitemid 40981742)
88. Karunakaran S, Diwakar L, Saeed U, Agarwal V, Ramakrishnan S, Iyengar S, and Ravindranath V. Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: Protection by alpha-lipoic acid. FASEB J 21: 2226-2236, 2007. (Pubitemid 47026457)
89. Karunakaran S, Saeed U, Ramakrishnan S, Koumar RC, and Ravindranath V. Constitutive expression and functional characterization of mitochondrial glutaredoxin (Grx2) in mouse and human brain. Brain Res 1185: 8-17, 2007. (Pubitemid 350176571)
90. Kawamata H and Manfredi G. Import, maturation, and function of SOD1 and its copper chaperone CCS in the mitochondrial intermembrane space. Antioxid Redox Signal 13: 1375-1384, 2010.
91. Kenchappa RS and Ravindranath V. Glutaredoxin is essential for maintenance of brain mitochondrial complex I: Studies with MPTP. FASEB J 17: 717-719, 2003.
92. Kidd SK and Schneider JS. Protective effects of valproic acid on the nigrostriatal dopamine system in a 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Neuroscience 194: 189-194, 2011.
93. Kil IS, Chung KH, and Park JW. Silencing of mitochondrial NADP+ -dependent isocitrate dehydrogenase gene enhances selenite-induced apoptosis. Free Radic Res 44: 332-339, 2010.
94. Kil IS and Park JW. Regulation of mitochondrial NADP+ - dependent isocitrate dehydrogenase activity by glutathionylation. J Biol Chem 280: 10846-10854, 2005.
95. Kim RH, Smith PD, Aleyasin H, Hayley S, Mount MP, Pownall S, Wakeham A, You-Ten AJ, Kalia SK, Horne P, Westaway D, Lozano AM, Anisman H, Park DS, and Mak TW. Hypersensitivity of DJ-1-deficient mice to 1-methyl-4- phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci USA 102: 5215-5220, 2005.
96. Kim SY, Kim TJ, and Lee KY. A novel function of peroxiredoxin 1 (Prx-1) in apoptosis signal-regulating kinase 1 (ASK1)-mediated signaling pathway. FEBS Lett 582: 1913- 1918, 2008.
97. Kiyota T, Ingraham KL, Swan RJ, Jacobsen MT, Andrews SJ, and Ikezu T. AAV serotype 2/1-mediated gene delivery of anti-inflammatory interleukin-10 enhances neurogenesis and cognitive function in APP + PS1 mice. Gene Ther 2011 Sep 15. doi: 10.1038/gt.2011.126. [Epub ahead of print] http://www.ncbi.nim.nih. gov/pubmed/21918553.
98. Klatt P, Molina EP, and Lamas S. Nitric oxide inhibits c-Jun DNA binding by specifically targeted S-glutathionylation. J Biol Chem 274: 15857-15864, 1999.
99. Kokoszka JE, Waymire KG, Levy SE, Sligh JE, Cai J, Jones DP, MacGregor GR, and Wallace DC. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 427: 461-465, 2004. (Pubitemid 38168501)
100. Kumar P, Kalonia H, and Kumar A. Huntington's disease: Pathogenesis to animal models. Pharmacol Rep 62: 1-14, 2010.
101. Lam PY, Yin F, Hamilton RT, Boveris A, and Cadenas E. Elevated neuronal nitric oxide synthase expression during ageing and mitochondrial energy production. Free Radic Res 43: 431-439, 2009.
102. Lee DW, Kaur D, Chinta SJ, Rajagopalan S, and Andersen J. A Disruption in iron-sulfur center biogenesis via inhibition of mitochondrial dithiol glutaredoxin 2 may contribute to mitochondrial and cellular iron dysregulation inmammalian glutathione-depleted dopaminergic cells: Implications for Parkinsons disease. Antioxid Redox Signal 9: 2083-2094, 2009.
103. Lee YM, Park SH, Shin DI, Hwang JY, Park B, Park YJ, Lee TH, Chae HZ, Jin BK, Oh TH, and Oh YJ. Oxidative modification of peroxiredoxin is associated with druginduced apoptotic signaling in experimental models of Parkinson disease. J Biol Chem 283: 9986-9998, 2008.
104. Leist M, Volbracht C, Fava E, and Nicotera P. 1-Methyl-4- phenylpyridinium induces autocrine excitotoxicity, protease activation, and neuronal apoptosis. Mol Pharmacol 54: 789-801, 1998. (Pubitemid 28523171)
105. Lillig CH, Berndt C, Vergnolle O, Lonn ME, Hudemann C, Bill E, and Holmgren A. Characterization of human glutaredoxin 2 as iron-sulfur protein: A possible role as redox sensor. Proc Natl Acad Sci USA 102: 8168-8173, 2005. (Pubitemid 40800061)
106. Lin MT and Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443: 787-795, 2006. (Pubitemid 44622683)
107. Lovell MA, Xie C, Gabbita SP, and Markesbery WR. Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease brain. Free Radic Biol Med 28: 418-427, 2000. (Pubitemid 30110658)
108. Lowther WT and Haynes AC. Reduction of cysteine sulfinic acid in eukaryotic, typical 2-Cys peroxiredoxins by sulfiredoxin. Antioxid Redox Signal 15: 99-109, 2011.
109. Maguire-Zeiss KA, Short DW, and Federoff HJ. Synuclein, dopamine and oxidative stress: Co-conspirators in Parkinson's disease? Brain Res Mol Brain Res 134: 18-23, 2005. (Pubitemid 40409494)
110. Mailloux RJ, Seifert EL, Bouillaud F, Aguer C, Collins S, and Harper ME. Glutathionylation acts as a control switch for uncoupling proteins UCP2 and UCP3. J Biol Chem 286: 21865-21875, 2011.
111. Mancuso M, Coppede F, Migliore L, Siciliano G, and Murri L. Mitochondrial dysfunction, oxidative stress and neurodegeneration. J Alzheimers Dis 10: 59-73, 2006. (Pubitemid 44401367)
112. Markesbery WR. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23: 134-147, 1997. (Pubitemid 27217017)
113. Martin HL and Teismann P. Glutathione-A review on its role and significance in Parkinson's disease. FASEB J 23: 3263-3272, 2009.
114. Matsuzawa A and Ichijo H. Redox control of cell fate by MAP kinase: Physiological roles of ASK1-MAP kinase pathway in stress signaling. Biochim Biophys Acta 1780: 1325-1336, 2008.
115. Mattson MP. Calcium and neurodegeneration. Aging Cell 6: 337-350, 2007.
116. Mazzola JL and Sirover MA. Reduction of glyceraldehyde- 3-phosphate dehydrogenase activity in Alzheimer's disease and in Huntington's disease fibroblasts. J Neurochem 76: 442-449, 2001. (Pubitemid 32097022)
117. McGeer PL, Itagaki S, Boyes BE, and McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38: 1285-1291, 1988.
118. Mieyal JJ, Gallogly MM, Qanungo S, Sabens EA, and Shelton MD. Molecular mechanisms and clinical implications of reversible protein S-glutathionylation. Antioxid Redox Signal 10: 1941-1988, 2008.
119. Mieyal JJ, Srinivasan U, Starke DW, Gravina SA, and Mieyal PA. Glutathionyl specificity of the thioltransferases: Mechanistic and physiological implications. Packer L and Cadenas E. 1995. Marcel Dekker, Inc. Biothiols in Health and Disease. Ref Type: Serial (Book, Monograph), pp. 305- 372.
120. Mogi M, Kondo T, Mizuno Y, and Nagatsu T. p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain. Neurosci Lett 414: 94-97, 2007. (Pubitemid 46241643)
121. Mohr S, Hallak H, de Boitte A, Lapetina EG, and Brune B. Nitric oxide-induced S-glutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 274: 9427-9430, 1999.
122. Murata H, Ihara Y, Nakamura H, Yodoi J, Sumikawa K, and Kondo T. Glutaredoxin exerts an antiapoptotic effect by regulating the redox state of Akt. J Biol Chem 278: 50226-50233, 2003. (Pubitemid 37548863)
123. Nakajima H, Amano W, Fujita A, Fukuhara A, Azuma YT, Hata F, Inui T, and Takeuchi T. The active site cysteine of the proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase is essential in oxidative stress-induced aggregation and cell death. J Biol Chem 282: 26562-26574, 2007. (Pubitemid 47443820)
124. Nakamura T and Lipton SA. Redox modulation by Snitrosylation contributes to proteinmisfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases. Cell Death Differ 18: 1478-1486, 2011.
125. Nassif M and Hetz C. Targeting autophagy in ALS: A complex mission. Autophagy 7: 450-453, 2011.
126. Newman SF, Sultana R, Perluigi M, Coccia R, Cai J, Pierce WM, Klein JB, Turner DM, and Butterfield DA. An increase in S-glutathionylated proteins in the Alzheimer's disease inferior parietal lobule. A proteomics approach. J Neurosci Res 85: 1506-1514, 2007. (Pubitemid 46724394)
127. Nilsen LH, Shi Q, Gibson GE, and Sonnewald U. Brain [U- (13) C]glucose metabolism in mice with decreased alphaketoglutarate dehydrogenase complex activity. J Neurosci Res 89: 1997-2007, 2011.
128. Norenberg MD and Rao KV. The mitochondrial permeability transition in neurologic disease. Neurochem Int 50: 983-997, 2007. (Pubitemid 46962816)
129. Nulton-Persson AC, Starke DW, Mieyal JJ, and Szweda LI. Reversible inactivation of alpha-ketoglutarate dehydrogenase in response to alterations in the mitochondrial glutathione status. Biochemistry 42: 4235-4242, 2003. (Pubitemid 36418317)
130. Obin M, Shang F, Gong X, Handelman G, Blumberg J, and Taylor A. Redox regulation of ubiquitin-conjugating enzymes: Mechanistic insights using the thiol-specific oxidant diamide. FASEB J 12: 561-569, 1998. (Pubitemid 28183515)
131. Okada K, Wangpoengtrakul C, Osawa T, Toyokuni S, Tanaka K, and Uchida K. 4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules. J Biol Chem 274: 23787-23793, 1999.
132. Okun E, Griffioen KJ, Lathia JD, Tang SC, Mattson MP, and Arumugam TV. Toll-like receptors in neurodegeneration. Brain Res Rev 59: 278-292, 2009.
133. Olanow CW and Tatton WG. Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 22: 123-144, 1999.
134. Opii WO, Nukala VN, Sultana R, Pandya JD, Day KM, Merchant ML, Klein JB, Sullivan PG, and Butterfield DA. Proteomic identification of oxidized mitochondrial proteins following experimental traumatic brain injury. J Neurotrauma 24: 772-789, 2007. (Pubitemid 46799270)
135. Ouyang M and Shen X. Critical role of ASK1 in the 6- hydroxydopamine- induced apoptosis in human neuroblastoma SH-SY5Y cells. J Neurochem 97: 234-244, 2006.
136. Pai HV, Starke DW, Lesnefsky EJ, Hoppel CL, and Mieyal JJ. What is the functional significance of the unique location of glutaredoxin 1 (GRx1) in the intermembrane space of mitochondria? Antioxid Redox Signal 9: 2027-2033, 2007. (Pubitemid 47622345)
137. Pappolla MA, Omar RA, Kim KS, and Robakis NK. Immunohistochemical evidence of oxidative [corrected] stress in Alzheimer's disease. Am J Pathol 140: 621-628, 1992.
138. Park HS, Cho SG, Kim CK, Hwang HS, Noh KT, Kim MS, Huh SH, Kim MJ, Ryoo K, Kim EK, Kang WJ, Lee JS, Seo JS, Ko YG, Kim S, and Choi EJ. Heat shock protein hsp72 is a negative regulator of apoptosis signal-regulating kinase 1. Mol Cell Biol 22: 7721-7730, 2002. (Pubitemid 35217284)
139. Park JW, Mieyal JJ, Rhee SG, and Chock PB. Deglutathionylation of 2-Cys peroxiredoxin is specifically catalyzed by sulfiredoxin. J Biol Chem 284: 23364-23374, 2009.
140. Pastore A, Tozzi G, Gaeta LM, Bertini E, Serafini V, Di Cesare S, Bonetto V, Casoni F, Carrozzo R, Federici G, and Piemonte F. Actin glutathionylation increases in fibroblasts of patients with Friedreich's ataxia: A potential role in the pathogenesis of the disease. J Biol Chem 278: 42588-42595, 2003. (Pubitemid 37310532)
141. Patten DA, Germain M, Kelly MA, and Slack RS. Reactive oxygen species: Stuck in the middle of neurodegeneration. J Alzheimers Dis 20 Suppl 2: S357-S367, 2010.
142. Pearce RK, Owen A, Daniel S, Jenner P, and Marsden CD. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease. J Neural Transm 104: 661-677, 1997. (Pubitemid 27474680)
143. Perry VH, Nicoll JA, and Holmes C. Microglia in neurodegenerative disease. Nat Rev Neurol 6: 193-201, 2010.
144. Pham FH, Sugden PH, and Clerk A. Regulation of protein kinase B and 4E-BP1 by oxidative stress in cardiac myocytes. Circ Res 86: 1252-1258, 2000. (Pubitemid 30436666)
145. Piemonte F, Pastore A, Tozzi G, Tagliacozzi D, Santorelli FM, Carrozzo R, Casali C, Damiano M, Federici G, and Bertini E. Glutathione in blood of patients with Friedreich's ataxia. Eur J Clin Invest 31: 1007-1011, 2001. (Pubitemid 35300671)
146. Pimentel DR, Adachi T, Ido Y, Heibeck T, Jiang B, Lee Y, Melendez JA, Cohen RA, and Colucci WS. Strainstimulated hypertrophy in cardiac myocytes is mediated by reactive oxygen species-dependent Ras S-glutathiolation. J Mol Cell Cardiol 41: 613-622, 2006. (Pubitemid 44374531)
147. Qanungo S, Starke DW, Pai HV, Mieyal JJ, and Nieminen AL. Glutathione supplementation potentiates hypoxic apoptosis by S-glutathionylation of p65-NFkappaB. J Biol Chem 282: 18427-18436, 2007. (Pubitemid 47100260)
148. Qian L and Flood PM. Microglial cells and Parkinson's disease. Immunol Res 41: 155-164, 2008.
149. Queiroga CS, Almeida AS, Martel C, Brenner C, Alves PM, and Vieira HL. Glutathionylation of adenine nucleotide translocase induced by carbon monoxide prevents mitochondrial membrane permeabilization and apoptosis. J Biol Chem 285: 17077-17088, 2010.
150. Reddy PH. Mitochondrial dysfunction in aging and Alzheimer's disease: Strategies to protect neurons. Antioxid Redox Signal 9: 1647-1658, 2007. (Pubitemid 47462968)
151. Reynaert NL, van der Vliet A, Guala AS, McGovern T, Hristova M, Pantano C, Heintz NH, Heim J, Ho YS, Matthews DE, Wouters EF, and Janssen-Heininger YM. Dynamic redox control of NF-kappaB through glutaredoxin- regulated S-glutathionylation of inhibitory kappaB kinase beta. Proc Natl Acad Sci USA 103: 13086-13091, 2006. (Pubitemid 44338920)
152. Riedlerer PF. Views on neurodegeneration as a basis for neuroprotective strategies. Med Sci Monit 10: RA287-RA290, 2004.
153. Romero JM and Bizzozero OA. Intracellular glutathione mediates the denitrosylation of protein nitrosothiols in the rat spinal cord. J Neurosci Res 87: 701-709, 2009.
154. Sabens EA, Distler AM, and Mieyal JJ. Levodopa deactivates enzymes that regulate thiol-disulfide homeostasis and promotes neuronal cell death: Implications for therapy of Parkinson's disease. Biochemistry 49: 2715-2724, 2010.
155. Sabens E, Stellar K, and Mieyal JJ. Levodopa activates apoptosis activating kinase 1 (ASK1) and promotes apoptosis in a neuronal model: Implications for Parkinson's disease. Chem Res in Toxicol 24: 1644-1652, 2011.
156. Saeed U, Durgadoss L, Valli RK, Joshi DC, Joshi PG, and Ravindranath V. Knockdown of cytosolic glutaredoxin 1 leads to loss of mitochondrial membrane potential: Implication in neurodegenerative diseases. PLoS ONE 3: e2459, 2008.
157. Saeed U, Ray A, Valli RK, Kumar AM, and Ravindranath V. DJ-1 Loss by glutaredoxin but not glutathione depletion triggers Daxx translocation and cell death. Antioxid Redox Signal 13: 127-144, 2010.
158. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, and Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signalregulating kinase (ASK) 1. EMBO J 17: 2596-2606, 1998. (Pubitemid 28221195)
159. Santos R, Lefevre S, Sliwa D, Seguin A, Camadro JM, and Lesuisse E. Friedreich ataxia: Molecular mechanisms, redox considerations, and therapeutic opportunities. Antioxid Redox Signal 13: 651-690, 2010.
160. Schwartz M and Shechter R. Systemic inflammatory cells fight off neurodegenerative disease. Nat Rev Neurol 6: 405-410, 2010.
161. Shelton MD, Chock PB, and Mieyal JJ. Glutaredoxin: Role in reversible protein S-glutathionylation and regulation of redox signal transduction and protein translocation. Antioxid Redox Signal 7: 348-366, 2005. (Pubitemid 40279804)
162. Shelton MD, Distler AM, Kern TS, and Mieyal JJ. Glutaredoxin regulates autocrine and paracrine proinflammatory responses in retinal glial (Muller) cells. J Biol Chem 284: 4760-4766, 2009.
163. Shelton MD, Kern TS, and Mieyal JJ. Glutaredoxin regulates nuclear factor kappa-B and intercellular adhesion molecule in Muller cells: Model of diabetic retinopathy. J Biol Chem 282: 12467-12474, 2007. (Pubitemid 47100623)
164. Shi Q, Xu H, Yu H, Zhang N, Ye Y, Estevez AG, Deng H, and Gibson GE. Inactivation and reactivation of the mitochondrial {alpha}-ketoglutarate dehydrogenase complex. J Biol Chem 286: 17640-17648, 2011.
165. Shimohama S, Tanino H, Kawakami N, Okamura N, Kodama H, Yamaguchi T, Hayakawa T, Nunomura A, Chiba S, Perry G, Smith MA, and Fujimoto S. Activation of NADPH oxidase in Alzheimer's disease brains. Biochem Biophys Res Commun 273: 5-9, 2000. (Pubitemid 30426853)
166. Shin JH, Ko HS, Kang H, Lee Y, Lee YI, Pletinkova O, Troconso JC, Dawson VL, and Dawson TM. PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson's disease. Cell 144: 689-702, 2011.
167. Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F, Jenner P, and Marsden CD. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 36: 348-355, 1994. (Pubitemid 24280055)
168. Smith MA, Nunomura A, Zhu X, Takeda A, and Perry G. Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease. Antioxid Redox Signal 2: 413-420, 2000.
169. Smyth GE and Colman RF. Cysteinyl peptides of pig heart NADP-dependent isocitrate dehydrogenase that are modified upon inactivation by N-ethylmaleimide. J Biol Chem 266: 14918-14925, 1991. (Pubitemid 21907597)
170. Song IS, Kim SU, Oh NS, Kim J, Yu DY, Huang SM, Kim JM, Lee DS, and Kim NS. Peroxiredoxin I contributes to TRAIL resistance through suppression of redox-sensitive caspase activation in human hepatoma cells. Carcinogenesis 30: 1106-1114, 2009.
171. Song JJ and Lee YJ. Differential role of glutaredoxin and thioredoxin in metabolic oxidative stress-induced activation of apoptosis signal-regulating kinase 1. Biochem J 373: 845-853, 2003. (Pubitemid 36981094)
172. 2. J Biol Chem 277: 46566-46575, 2002. (Pubitemid 35417655)
173. Song W, Chen J, Petrilli A, Liot G, Klinglmayr E, Zhou Y, Poquiz P, Tjong J, Pouladi MA, Hayden MR, Masliah E, Ellisman M, Rouiller I, Schwarzenbacher R, Bossy B, Perkins G, and Bossy-Wetzel E. Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat Med 17: 377-382, 2011.
174. Sparaco M, Gaeta LM, Tozzi G, Bertini E, Pastore A, Simonati A, Santorelli FM, and Piemonte F. Protein glutathionylation in human central nervous system: Potential role in redox regulation of neuronal defense against free radicals. J Neurosci Res 83: 256-263, 2006. (Pubitemid 43184389)
175. Sriram K and O'Callaghan JP. Divergent roles for tumor necrosis factor-alpha in the brain. J Neuroimmune Pharmacol 2: 140-153, 2007.
176. Steinert JR, Chernova T, and Forsythe ID. Nitric oxide signaling in brain function, dysfunction, and dementia. Neuroscientist 16: 435-452, 2010.
177. Sultana R, Poon HF, Cai J, Pierce WM, Merchant M, Klein JB, Markesbery WR, and Butterfield DA. Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach. Neurobiol Dis 22: 76-87, 2006.
178. Supnet C and Bezprozvanny I. Neuronal calcium signaling, mitochondrial dysfunction, and Alzheimer's disease. J Alzheimers Dis 20 Suppl 2: S487-S498, 2010.
179. Taylor ER, Hurrell F, Shannon RJ, Lin TK, Hirst J, and Murphy MP. Reversible glutathionylation of complex I increases mitochondrial superoxide formation. J Biol Chem 278: 19603-19610, 2003. (Pubitemid 36799143)
180. Tew KD and Townsend DM. Regulatory functions of glutathione S-transferase P1-1 unrelated to detoxification. Drug Metab Rev 43: 179-193, 2011.
181. Tillement L, Lecanu L, and Papadopoulos V. Alzheimer's disease: Effects of beta-amyloid on mitochondria. Mitochondrion 11: 13-21, 2011.
182. Tretter L, Sipos I and Adam-Vizi V. Initiation of neuronal damage by complex I deficiency and oxidative stress in Parkinson's disease. Neurochem Res 29: 569-577, 2004. (Pubitemid 38295007)
183. van HJ, Witte ME, Schreibelt G, and de Vries HE. Radical changes in multiple sclerosis pathogenesis. Biochim Biophys Acta 1812: 141-150, 2011.
184. Velu CS, Niture SK, Doneanu CE, Pattabiraman N, and Srivenugopal KS. Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-binding domain during oxidative stress. Biochemistry 46: 7765-7780, 2007. (Pubitemid 47016060)
185. Vesce S, Jekabsons MB, Johnson-Cadwell LI, and Nicholls DG. Acute glutathione depletion restricts mitochondrial ATP export in cerebellar granule neurons. J Biol Chem 280: 38720-38728, 2005. (Pubitemid 43853775)
186. Waak J, Weber SS, Gorner K, Schall C, Ichijo H, Stehle T, and Kahle PJ. Oxidizable residues mediating protein stability and cytoprotective interaction of DJ-1 with apoptosis signalregulating kinase 1. J Biol Chem 284: 14245-14257, 2009.
187. Wang J, Boja ES, Tan W, Tekle E, Fales HM, English S, Mieyal JJ, and Chock PB. Reversible glutathionylation regulates actin polymerization in A431 cells. J Biol Chem 276: 47763-47766, 2001.
188. Wang J, Tekle E, Oubrahim H, Mieyal JJ, Stadtman ER, and Chock PB. Stable and controllable RNA interference: Investigating the physiological function of glutathionylated actin. Proc Natl Acad Sci USA 100: 5103-5106, 2003. (Pubitemid 36542665)
189. Wang W, Oliva C, Li G, Holmgren A, Lillig CH, and Kirk KL. Reversible silencing of CFTR chloride channels by glutathionylation. J Gen Physiol 125: 127-141, 2005. (Pubitemid 40224113)
190. West MB, Hill BG, Xuan YT, and Bhatnagar A. Protein glutathiolation by nitric oxide: An intracellular mechanism regulating redox protein modification. FASEB J 20: 1715-1717, 2006.
191. West XZ, Malinin NL, Merkulova AA, Tischenko M, Kerr BA, Borden EC, Podrez EA, Salomon RG, and Byzova TV. Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature 467: 972-976, 2010.
192. Wu DC, Teismann P, Tieu K, Vila M, Jackson-Lewis V, Ischiropoulos H, and Przedborski S. NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine model of Parkinson's disease. Proc Natl Acad Sci USA 100: 6145-6150, 2003. (Pubitemid 36576945)
193. Wyss-Coray T and Mucke L. Inflammation in neurodegenerative disease-Aa double-edged sword. Neuron 35: 419-432, 2002. (Pubitemid 34879943)
194. Xu R, Wu C, Zhang X, Zhang Q, Yang Y, Yi J, Yang R, and Tao Y. Linking hypoxic and oxidative insults to cell death mechanisms in models of ALS. Brain Res 1372: 133-144, 2011.
195. Yang Q and Mao Z. Regulation of MEF2s by chaperonemediated autophagy. Cell Cycle 8: 1105, 2009.
196. Yang Q and Mao Z. Parkinson disease: A role for autophagy? Neuroscientist 16: 335-341, 2010.
197. Yang Y, Shi W, Cui N, Wu Z, and Jiang C. Oxidative stress inhibits vascular K(ATP) channels by S-glutathionylation. J Biol Chem 285: 38641-38648, 2010.
198. Yang Z, Cheng W, Hong L, Chen W, Wang Y, Lin S, Han J, Zhou H, and Gu J. Adenine nucleotide (ADP/ATP) translocase 3 participates in the tumor necrosis factor induced apoptosis of MCF-7 cells. Mol Biol Cell 18: 4681-4689, 2007. (Pubitemid 350060192)
199. Yao D, Gu Z, Nakamura T, Shi ZQ, Ma Y, Gaston B, Palmer LA, Rockenstein EM, Zhang Z, Masliah E, Uehara T, and Lipton SA. Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. Proc Natl Acad SciUSA 101: 10810-10814, 2004. (Pubitemid 38955824)
200. Zemlan FP, Thienhaus OJ, and Bosmann HB. Superoxide dismutase activity in Alzheimer's disease: Possible mechanism for paired helical filament formation. Brain Res 476: 160-162, 1989. (Pubitemid 19006378)
201. Zhang R, Luo D, Miao R, Bai L, Ge Q, Sessa WC, and Min W. Hsp90-Akt phosphorylates ASK1 and inhibits ASK1- mediated apoptosis. Oncogene 24: 3954-3963, 2005. (Pubitemid 40896407)
202. Ziegler DM. Role of reversible oxidation-reduction of enzyme thiols-disulfides in metabolic regulation. Annu Rev Biochem 54: 305-329, 1985. (Pubitemid 15073649)
203. Zmijewski JW, Banerjee S, and Abraham E. S-glutathionylation of the Rpn2 regulatory subunit inhibits 26 S proteasomal function. J Biol Chem 284: 22213-22221, 2009.